Yüklüyor......
(Not Giving Up) The Marathon Race of MET Targeting Therapy - Are We There Yet?
Among various MET aberrations, MET amplification and METex14 have emerged as valid predictive biomarkers for MET inhibition. Despite challenges that have limited the development of MET inhibitors, we can learn from the latest efforts in biomarker-based therapy to better identify the patients who wil...
Kaydedildi:
| Yayımlandı: | Clin Cancer Res |
|---|---|
| Yazar: | |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2019
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6504968/ https://ncbi.nlm.nih.gov/pubmed/30770350 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-18-3739 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|